Global Gene-based Advanced Therapy Medicinal market growth is projected to reach  US$ 15820 million in 2025 to US$ 49400 million in 2031; it is expected to grow at a CAGR of 20.9% from 2025 to 2031.

Global Gene-based Advanced Therapy Medicinal Market Trends and Analysis 2025-31

The global Gene-based Advanced Therapy Medicinal market size is predicted to grow from US$ 15820 million in 2025 to US$ 49400 million in 2031; it is expected to grow at a CAGR of 20.9% from 2025 to 2031. Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patients cells instead of using drugs or surgery. The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine. LPI (LP Information) newest research report, the Gene-based Advanced Therapy Medicinal Industry Forecast looks at past sales and reviews total world Gene-based Advanced Therapy Medicinal sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene-based Advanced Therapy Medicinal sales for 2025 through 2031. With Gene-based Advanced Therapy Medicinal sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene-based Advanced Therapy Medicinal industry. This Insight Report provides a comprehensive analysis of the global Gene-based Advanced Therapy Medicinal landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene-based Advanced Therapy Medicinal portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Gene-based Advanced Therapy Medicinal market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene-based Advanced Therapy Medicinal and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene-based Advanced Therapy Medicinal. This report presents a comprehensive overview, market shares, and growth opportunities of Gene-based Advanced Therapy Medicinal market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Viral Gene Delivery System &nbsp;&nbsp;&nbsp; Non-viral Gene Delivery System Segmentation by Application: &nbsp;&nbsp;&nbsp; Neurological Diseases &nbsp;&nbsp;&nbsp; Cancer &nbsp;&nbsp;&nbsp; Other This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Biogen &nbsp;&nbsp;&nbsp; Novartis &nbsp;&nbsp;&nbsp; Gilead Sciences &nbsp;&nbsp;&nbsp; Sarepta Therapeutics &nbsp;&nbsp;&nbsp; Alnylam Pharmaceuticals &nbsp;&nbsp;&nbsp; Amgen &nbsp;&nbsp;&nbsp; Spark Therapeutics &nbsp;&nbsp;&nbsp; Akcea Therapeutics &nbsp;&nbsp;&nbsp; Sunway Biotech &nbsp;&nbsp;&nbsp; SIBIONO &nbsp;&nbsp;&nbsp; AnGes &nbsp;&nbsp;&nbsp; Orchard Therapeutics &nbsp;&nbsp;&nbsp; Human Stem Cells Institute

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Gene-based Advanced Therapy Medicinal Market Size (2020-2031) &nbsp;2.1.2 Gene-based Advanced Therapy Medicinal Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Gene-based Advanced Therapy Medicinal by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Gene-based Advanced Therapy Medicinal Segment by Type &nbsp;2.2.1 Viral Gene Delivery System &nbsp;2.2.2 Non-viral Gene Delivery System &nbsp;2.3 Gene-based Advanced Therapy Medicinal Market Size by Type &nbsp;2.3.1 Gene-based Advanced Therapy Medicinal Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2020-2025) &nbsp;2.4 Gene-based Advanced Therapy Medicinal Segment by Application &nbsp;2.4.1 Neurological Diseases &nbsp;2.4.2 Cancer &nbsp;2.4.3 Other &nbsp;2.5 Gene-based Advanced Therapy Medicinal Market Size by Application &nbsp;2.5.1 Gene-based Advanced Therapy Medicinal Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2020-2025) 3 Gene-based Advanced Therapy Medicinal Market Size by Player &nbsp;3.1 Gene-based Advanced Therapy Medicinal Market Size Market Share by Player &nbsp;3.1.1 Global Gene-based Advanced Therapy Medicinal Revenue by Player (2020-2025) &nbsp;3.1.2 Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Gene-based Advanced Therapy Medicinal Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Gene-based Advanced Therapy Medicinal by Region &nbsp;4.1 Gene-based Advanced Therapy Medicinal Market Size by Region (2020-2025) &nbsp;4.2 Global Gene-based Advanced Therapy Medicinal Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Gene-based Advanced Therapy Medicinal Market Size Growth (2020-2025) &nbsp;4.4 APAC Gene-based Advanced Therapy Medicinal Market Size Growth (2020-2025) &nbsp;4.5 Europe Gene-based Advanced Therapy Medicinal Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Gene-based Advanced Therapy Medicinal Market Size by Country (2020-2025) &nbsp;5.2 Americas Gene-based Advanced Therapy Medicinal Market Size by Type (2020-2025) &nbsp;5.3 Americas Gene-based Advanced Therapy Medicinal Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Gene-based Advanced Therapy Medicinal Market Size by Region (2020-2025) &nbsp;6.2 APAC Gene-based Advanced Therapy Medicinal Market Size by Type (2020-2025) &nbsp;6.3 APAC Gene-based Advanced Therapy Medicinal Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Gene-based Advanced Therapy Medicinal Market Size by Country (2020-2025) &nbsp;7.2 Europe Gene-based Advanced Therapy Medicinal Market Size by Type (2020-2025) &nbsp;7.3 Europe Gene-based Advanced Therapy Medicinal Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Gene-based Advanced Therapy Medicinal by Region (2020-2025) &nbsp;8.2 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Gene-based Advanced Therapy Medicinal Market Forecast &nbsp;10.1 Global Gene-based Advanced Therapy Medicinal Forecast by Region (2026-2031) &nbsp;10.1.1 Global Gene-based Advanced Therapy Medicinal Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.1.3 APAC Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.1.4 Europe Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.1.5 Middle East & Africa Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.2 Americas Gene-based Advanced Therapy Medicinal Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.2.2 Canada Market Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.2.3 Mexico Market Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.2.4 Brazil Market Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.3 APAC Gene-based Advanced Therapy Medicinal Forecast by Region (2026-2031) &nbsp;10.3.1 China Gene-based Advanced Therapy Medicinal Market Forecast &nbsp;10.3.2 Japan Market Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.3.3 Korea Market Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.3.4 Southeast Asia Market Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.3.5 India Market Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.3.6 Australia Market Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.4 Europe Gene-based Advanced Therapy Medicinal Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.4.2 France Market Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.4.3 UK Market Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.4.4 Italy Market Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.4.5 Russia Market Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.5 Middle East & Africa Gene-based Advanced Therapy Medicinal Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.5.2 South Africa Market Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.5.3 Israel Market Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.5.4 Turkey Market Gene-based Advanced Therapy Medicinal Forecast &nbsp;10.6 Global Gene-based Advanced Therapy Medicinal Forecast by Type (2026-2031) &nbsp;10.7 Global Gene-based Advanced Therapy Medicinal Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Gene-based Advanced Therapy Medicinal Forecast 11 Key Players Analysis &nbsp;11.1 Biogen &nbsp;11.1.1 Biogen Company Information &nbsp;11.1.2 Biogen Gene-based Advanced Therapy Medicinal Product Offered &nbsp;11.1.3 Biogen Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Biogen Main Business Overview &nbsp;11.1.5 Biogen Latest Developments &nbsp;11.2 Novartis &nbsp;11.2.1 Novartis Company Information &nbsp;11.2.2 Novartis Gene-based Advanced Therapy Medicinal Product Offered &nbsp;11.2.3 Novartis Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Novartis Main Business Overview &nbsp;11.2.5 Novartis Latest Developments &nbsp;11.3 Gilead Sciences &nbsp;11.3.1 Gilead Sciences Company Information &nbsp;11.3.2 Gilead Sciences Gene-based Advanced Therapy Medicinal Product Offered &nbsp;11.3.3 Gilead Sciences Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Gilead Sciences Main Business Overview &nbsp;11.3.5 Gilead Sciences Latest Developments &nbsp;11.4 Sarepta Therapeutics &nbsp;11.4.1 Sarepta Therapeutics Company Information &nbsp;11.4.2 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Product Offered &nbsp;11.4.3 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Sarepta Therapeutics Main Business Overview &nbsp;11.4.5 Sarepta Therapeutics Latest Developments &nbsp;11.5 Alnylam Pharmaceuticals &nbsp;11.5.1 Alnylam Pharmaceuticals Company Information &nbsp;11.5.2 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Product Offered &nbsp;11.5.3 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Alnylam Pharmaceuticals Main Business Overview &nbsp;11.5.5 Alnylam Pharmaceuticals Latest Developments &nbsp;11.6 Amgen &nbsp;11.6.1 Amgen Company Information &nbsp;11.6.2 Amgen Gene-based Advanced Therapy Medicinal Product Offered &nbsp;11.6.3 Amgen Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Amgen Main Business Overview &nbsp;11.6.5 Amgen Latest Developments &nbsp;11.7 Spark Therapeutics &nbsp;11.7.1 Spark Therapeutics Company Information &nbsp;11.7.2 Spark Therapeutics Gene-based Advanced Therapy Medicinal Product Offered &nbsp;11.7.3 Spark Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Spark Therapeutics Main Business Overview &nbsp;11.7.5 Spark Therapeutics Latest Developments &nbsp;11.8 Akcea Therapeutics &nbsp;11.8.1 Akcea Therapeutics Company Information &nbsp;11.8.2 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Product Offered &nbsp;11.8.3 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Akcea Therapeutics Main Business Overview &nbsp;11.8.5 Akcea Therapeutics Latest Developments &nbsp;11.9 Sunway Biotech &nbsp;11.9.1 Sunway Biotech Company Information &nbsp;11.9.2 Sunway Biotech Gene-based Advanced Therapy Medicinal Product Offered &nbsp;11.9.3 Sunway Biotech Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 Sunway Biotech Main Business Overview &nbsp;11.9.5 Sunway Biotech Latest Developments &nbsp;11.10 SIBIONO &nbsp;11.10.1 SIBIONO Company Information &nbsp;11.10.2 SIBIONO Gene-based Advanced Therapy Medicinal Product Offered &nbsp;11.10.3 SIBIONO Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 SIBIONO Main Business Overview &nbsp;11.10.5 SIBIONO Latest Developments &nbsp;11.11 AnGes &nbsp;11.11.1 AnGes Company Information &nbsp;11.11.2 AnGes Gene-based Advanced Therapy Medicinal Product Offered &nbsp;11.11.3 AnGes Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.11.4 AnGes Main Business Overview &nbsp;11.11.5 AnGes Latest Developments &nbsp;11.12 Orchard Therapeutics &nbsp;11.12.1 Orchard Therapeutics Company Information &nbsp;11.12.2 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Product Offered &nbsp;11.12.3 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.12.4 Orchard Therapeutics Main Business Overview &nbsp;11.12.5 Orchard Therapeutics Latest Developments &nbsp;11.13 Human Stem Cells Institute &nbsp;11.13.1 Human Stem Cells Institute Company Information &nbsp;11.13.2 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Product Offered &nbsp;11.13.3 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.13.4 Human Stem Cells Institute Main Business Overview &nbsp;11.13.5 Human Stem Cells Institute Latest Developments 12 Research Findings and Conclusion

Report	Global Gene-based Advanced Therapy Medicinal Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI13703

Buyer Information

Order Summary